PMID: 9171369May 15, 1997Paper

Brca2 is required for embryonic cellular proliferation in the mouse

Genes & Development
A SuzukiT W Mak

Abstract

Mutations of the tumor suppressor gene BRCA2 are associated with predisposition to breast and other cancers. Homozygous mutant mice in which exons 10 and 11 of the Brca2 gene were deleted by gene targeting (Brca2(10-11)) die before day 9.5 of embryogenesis. Mutant phenotypes range from severely developmentally retarded embryos that do not gastrulate to embryos with reduced size that make mesoderm and survive until 8.5 days of development. Although apoptosis is normal, cellular proliferation is impaired in Brca2(10-11) mutants, both in vivo and in vitro. In addition, the expression of the cyclin-dependent kinase inhibitor p21 is increased. Thus, Brca2(10-11) mutants are similar in phenotype to Brca1(5-6) mutants but less severely affected. Expression of either of these two genes was unaffected in mutant embryos of the other. This study shows that Brca2, like Brca1, is required for cellular proliferation during embryogenesis. The similarity in phenotype between Brca1 and Brca2 mutants suggests that these genes may have cooperative roles or convergent functions during embryogenesis.

References

Jan 1, 1991·Annual Review of Biophysics and Biophysical Chemistry·S C Kowalczykowski
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M F HansenW K Cavenee
Jan 1, 1986·Annals of the New York Academy of Sciences·D L Kleinberg, C B Newman
May 1, 1988·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Y HayashiT Hoshino
Jan 1, 1986·Annals of the New York Academy of Sciences·P K SiiteriJ Murai
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G M Church, W Gilbert
Jun 1, 1995·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·L S Cox, D P Lane
Aug 26, 1995·Lancet·S ThorlaciusJ E Eyfjord
Oct 7, 1994·Science·P A FutrealY Miki
Sep 22, 1994·Nature·F GuillemotA L Joyner
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Aug 27, 1993·Cell·J A KreidbergR Jaenisch
Mar 1, 1996·Nature Genetics·S V TavtigianD E Goldgar
Jun 1, 1996·Nature Genetics·Y MikiY Nakamura
Jun 15, 1996·Genes & Development·R Kolodner
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·J V RajanL A Chodosh
Feb 7, 1997·Cell·T Hunter

❮ Previous
Next ❯

Citations

Aug 31, 2010·Irish Journal of Medical Science·E M Y Saleh, R A E El-Awady
Apr 23, 2003·Journal of Molecular Biology·Cecilia LundinThomas Helleday
Aug 1, 1998·Mutation Research·S Venkatachalam, L A Donehower
Sep 1, 1997·Trends in Genetics : TIG·A V Anagnostopoulos
Feb 1, 2000·Trends in Genetics : TIG·P L WelcshM C King
Mar 20, 2002·Biochimie·Ralph Scully, Nadine Puget
May 10, 2001·Current Opinion in Cell Biology·A R Venkitaraman
Jul 29, 1998·Molecular Medicine Today·J Feunteun
Mar 16, 2000·Breast Cancer Research and Treatment·H C JernströmH Olsson
Dec 11, 2007·Oncogene·T Thorslund, S C West
Dec 11, 2007·Oncogene·E R Phillips, P J McKinnon
Apr 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sridharan RajagopalanAlan R Fersht
Oct 27, 2010·Proceedings of the National Academy of Sciences of the United States of America·Heather R ShiveDennis D Hickstein
May 10, 2013·Proceedings of the National Academy of Sciences of the United States of America·Christian Bowman-ColinDavid M Livingston
Aug 24, 2002·Hybridoma and Hybridomics·Lisa K GilliamLaura P Hale
Oct 30, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Pothuri
Feb 18, 1999·The EMBO Journal·M Schorpp-KistnerE F Wagner
Jul 17, 1998·Journal of the National Cancer Institute·P J Biggs, A Bradley
Oct 16, 2003·Journal of the National Cancer Institute·Kenneth OffitArleen D Auerbach
Apr 17, 2012·Nucleic Acids Research·Marie-Michelle GenoisJean-Yves Masson
Nov 5, 1999·The Nursing Spectrum·K A Calzone
Mar 21, 2000·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A R Venkitaraman
Dec 1, 2006·Molecular and Cellular Biology·Victoria L CressmanBeverly H Koller
May 11, 2000·Molecular and Cellular Biology·D J WilliamsonH E Ruley
Apr 3, 2001·Molecular and Cellular Biology·M J Meagher, R E Braun
Feb 28, 2002·Molecular and Cellular Biology·Ester M HammondAmato J Giaccia
Jan 1, 1997·Annual Review of Cell and Developmental Biology·J Kimble, P Simpson
Oct 29, 2008·Annual Review of Pathology·Ashok R Venkitaraman
Nov 13, 2012·The Journal of Clinical Investigation·Miki NishioAkira Suzuki
May 15, 2009·Regenerative Medicine·Ana KrtolicaRichard K Miller
Jul 1, 2008·Experimental & Molecular Medicine·Pil-Gu Park, Hyunsook Lee
Aug 13, 2011·Clinical Medicine Insights. Oncology·Pankaj TanejaKazushi Inoue

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.